Challenges in drug repurposing for rare diseases – the GNB1/KCNJ6 example
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Probing Inward Rectifier K+ Channel Gating and Conductance Guided by Disease Mutations
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Computational investigation of a rare disease
Theres Friesacher (Speaker) & Anna Weinzinger (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Visualizing individual protonation events in Kir2 channels
Michael Jirout (Speaker), Eva Maria Zangerl-Plessl (Contributor) & Anna Weinzinger (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Computational investigations of ion channels
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
FASEB: The Ion Channel Regulation Conference: Molecules to Disease
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Structure-dynamics-function relationships of inward rectifier K+ channels probed by in silico methods
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Computational investigations of cation channels
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
In silico modelling and drug interactions in Kir6.1
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Molecular modeling of Cantu Syndrome Channels
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Computational investigations of hERG K+ channels
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
MD SIMULATIONS OF KIRBAC1.1 MUTANTS REVEAL GATING CHANGES AT THE BUNDLE CROSSING REGION
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Investigating the structural basis of hERG channel block guided by molecular dynamics simulations
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
In silico modelling of Kir2.x channels
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
IK1 block by small molecules
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
In silico prediction of the cardiotoxicity of drug candidates
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Modelling the hERG K+ channel
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Towards a consensus model of the hERG K+ channel
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Computer modeling strategies to investigate the molecular basis of odor discrimination
Anna Weinzinger (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
PROSTAGLANDINES - POTENTIAL THERAPEUTICS FOR DEND SYNDROME?
1/12/20 → 30/07/23
Project: Research funding
Molecular Drug Targets
Hering, S., Ecker, G., Maulide, N., Weinzinger, A. & Gonzalez Herrero, L.
1/12/10 → 31/12/22
Project: Research funding
Department of Pharmaceutical Sciences
Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D178
T: +43-1-4277-55311